Prometric Exam Questions for Medical Microbiology Specialists 2026: 20 MCQs with Answers on Blood Culture Interpretation, Antimicrobial Susceptibility, Carbapenem Resistance, MRSA, Tuberculosis Diagnostics, Brucellosis, MERS-CoV, Fungal Infection, Infection Control and Stewardship

The specialist medical microbiology paper (MIC5251 at DHA, and the equivalent SCFHS, QCHP and NHRA papers) is 100 to 150 single-best-answer questions in up to three hours with a pass mark of about 60%. Candidates with an MD, DNB, FCPS, FRCPath or Arab Board in microbiology sit it after the authority confirms the title; microbiology technologists and clinical scientists sit separate papers (MIC5691 and MIC5692) with overlapping bench content. The Gulf's microbiology agenda is distinctive: multidrug-resistant Gram-negatives in ICUs, brucellosis and tuberculosis in an expatriate workforce, MERS-CoV, Candida auris outbreaks and mass gatherings at Hajj and Umrah. This set covers what recurs. The licensing route is in the pathologist guide.

Blood cultures and bacteriology basics

Question 1

One of two blood culture sets from a patient with a central line grows coagulase-negative staphylococci at 48 hours; the other set is negative, and the patient is afebrile with a normal white cell count. The most likely interpretation and advice are:

1. True bacteraemia; start vancomycin for 14 days
2. Probable contaminant, because coagulase-negative staphylococci in a single set with a long time to positivity and no clinical signs usually reflect skin flora; advise clinical review, repeat paired cultures (one peripheral, one through the line) if infection is suspected, and reinforce skin antisepsis and collection technique to keep contamination rates below the 3% benchmark
3. Endocarditis; echocardiography immediately
4. Laboratory error

Answer: B. Staphylococcus aureus, Streptococcus pneumoniae, Enterobacterales and Candida are never dismissed as contaminants; the same organism in both sets, short time to positivity and clinical signs favour true infection. Differential time to positivity over two hours supports line-related infection.

Question 2

A Gram stain of CSF from a 19-year-old with meningitis shows Gram-negative diplococci inside and outside neutrophils. The organism, the urgent actions and the public health implications are:

1. Streptococcus pneumoniae; no public health action
2. Neisseria meningitidis; immediate telephone report to the clinician (a critical result), culture on chocolate agar in carbon dioxide, PCR and serogrouping, notification to public health, chemoprophylaxis for close contacts and laboratory staff exposed to aerosols, and vaccination considerations; Hajj and Umrah pilgrims are required to hold meningococcal ACWY vaccination because of outbreaks linked to mass gatherings
3. Haemophilus influenzae; type b vaccine
4. Listeria monocytogenes; ampicillin

Answer: B. Gram-positive lancet-shaped diplococci suggest pneumococcus; Gram-positive rods suggest Listeria in neonates, the elderly and the immunosuppressed.

Question 3

Which statement about antimicrobial susceptibility reporting is correct under current EUCAST or CLSI practice?

1. An MIC above the breakpoint always means the drug cannot be used at any dose
2. Results are categorised as susceptible at standard dosing, susceptible at increased exposure (EUCAST "I") or resistant, using clinical breakpoints that are updated annually; the laboratory applies selective and cascade reporting to encourage narrow-spectrum choices, suppresses inappropriate agents (for example cephalosporins for enterococci, which are intrinsically resistant), and adds expert rules such as reporting all cephalosporins resistant for ESBL producers where the guideline requires
3. Disc diffusion cannot be used for any organism
4. Breakpoints never change

Answer: B. Intrinsic resistance tables (for example Klebsiella to ampicillin, Pseudomonas to ertapenem, Stenotrophomonas to carbapenems) are tested regularly.

Antimicrobial resistance

Question 4

A Klebsiella pneumoniae from a urine culture is resistant to cefotaxime and ceftazidime, with a marked increase in zone size when clavulanate is added. The mechanism, confirmation and reporting are:

1. AmpC beta-lactamase; report cephalosporins as susceptible
2. Extended-spectrum beta-lactamase (ESBL) production, confirmed by the combination disc or double-disc synergy test and reported with a comment; carbapenems or, for lower urinary tract infection, nitrofurantoin or fosfomycin are options, and the patient is placed on contact precautions per hospital policy
3. Carbapenemase production; colistin
4. Porin loss; no treatment

Answer: B. AmpC enzymes are not inhibited by clavulanate and are inducible in Enterobacter, Citrobacter and Serratia; CTX-M is the dominant ESBL family in the region.

Question 5

An ICU isolate of Klebsiella pneumoniae has a meropenem MIC of 16 mg/L and a positive modified carbapenem inactivation method test. Which further tests and actions are indicated?

1. Report resistant and take no further action
2. Identify the carbapenemase type (lateral-flow immunoassay or PCR for KPC, NDM, OXA-48, VIM, IMP), because the type determines treatment (ceftazidime-avibactam for KPC and OXA-48, aztreonam-avibactam or cefiderocol for metallo-beta-lactamases, with colistin and tigecycline as reserve agents), notify infection control immediately for contact isolation and screening of contacts, and report to the national surveillance system
3. Give meropenem at a higher dose only
4. Discharge the patient

Answer: B. OXA-48 and NDM carbapenemases are endemic in Gulf hospitals; rectal screening on ICU admission and after transfer from other hospitals is standard in many Gulf facilities.

Question 6

Which statement about MRSA laboratory detection is correct?

1. Penicillin susceptibility reliably identifies MRSA
2. Methicillin resistance is mediated by mecA (or mecC) encoding PBP2a, detected phenotypically with a cefoxitin disc or MIC (oxacillin is less reliable) and by PCR or latex agglutination for PBP2a; chromogenic agar or PCR on nasal swabs is used for screening, and MRSA-positive patients are isolated with contact precautions and decolonised where policy applies; vancomycin MICs are reported, with alternatives (linezolid, daptomycin, ceftaroline) for MIC creep or treatment failure
3. Vancomycin resistance in S. aureus is common
4. MRSA cannot be detected by PCR

Answer: B. Community-associated MRSA (often PVL-positive, SCCmec IV) causes skin and soft tissue infection and necrotising pneumonia; PVL testing is reported to infection control.

Question 7

Which laboratory algorithm is recommended for diagnosing Clostridioides difficile infection?

1. Stool culture alone
2. A two-step algorithm on unformed stool only (the laboratory rejects formed stool and samples from children under one year): a sensitive screen with glutamate dehydrogenase antigen or toxin gene PCR, followed by a specific toxin A/B enzyme immunoassay; GDH or PCR positive with toxin negative indicates possible colonisation and needs clinical correlation, and testing of cure is not performed
3. Toxin EIA alone
4. Blood cultures

Answer: B. Ribotype 027 and other hypervirulent strains cause outbreaks; alcohol gel does not kill spores, so soap-and-water hand hygiene and sporicidal cleaning are required.

Regionally important infections

Question 8

A South Asian construction worker has a cough for four weeks, night sweats and an upper lobe cavity. Sputum smear is positive for acid-fast bacilli and a rapid molecular test detects Mycobacterium tuberculosis with rifampicin resistance. The laboratory's responsibilities include:

1. Reporting the smear and nothing more
2. Immediate telephone notification of the clinician and infection control (airborne isolation), notification to public health as a reportable disease with residency implications in Gulf states, culture on liquid (MGIT) and solid media with identification, phenotypic drug susceptibility testing for first- and second-line drugs, and a line-probe assay or sequencing for isoniazid and fluoroquinolone resistance to guide an MDR-TB regimen, with the specimen handled in a biosafety level 3 facility
3. Repeat the smear only
4. Culture is unnecessary after PCR

Answer: B. Pre-employment and residency medical screening for tuberculosis is mandatory across the Gulf, and the laboratory's results feed directly into public health and immigration decisions.

Question 9

A Saudi farmer with a two-week undulating fever, sweats, arthralgia and a history of drinking raw camel milk has a blood culture that flags positive at day five with small Gram-negative coccobacilli. The laboratory should:

1. Discard the culture as a contaminant
2. Suspect Brucella, handle the isolate only in a biosafety cabinet at containment level 3 with no sniffing or open-bench work (Brucella is a frequent cause of laboratory-acquired infection), confirm by MALDI-TOF with caution or PCR and serology (standard agglutination test, with titres of 1:160 or more significant in endemic areas), and advise prolonged combination therapy (doxycycline plus rifampicin, or doxycycline plus an aminoglycoside) with follow-up for relapse
3. Report as Haemophilus and give amoxicillin
4. Give a single dose of ciprofloxacin

Answer: B. Brucellosis is among the most common zoonoses in Saudi Arabia and Oman; blood cultures are held for extended incubation when brucellosis is suspected, and exposed laboratory staff receive prophylaxis and serological follow-up.

Question 10

A 60-year-old man with diabetes and recent contact with dromedary camels has severe pneumonia and acute kidney injury. The most important respiratory diagnostic step and precautions are:

1. A rapid influenza antigen test only
2. Lower respiratory tract sampling (sputum, tracheal aspirate or bronchoalveolar lavage, which have higher yield than upper respiratory swabs) for MERS-CoV real-time RT-PCR targeting two genomic regions, alongside a multiplex respiratory virus panel and bacterial cultures, with the patient managed under airborne and contact precautions in a negative-pressure room, immediate notification to public health, and contact tracing; repeat testing is needed if the first sample is negative and suspicion remains
3. Serology alone
4. No isolation until results return

Answer: B. MERS-CoV has caused hospital outbreaks in Saudi Arabia, Korea and the UAE with healthcare worker transmission; healthcare-associated amplification is the recurring lesson.

Question 11

A returning traveller from Nigeria has fever and a thick film showing numerous ring forms with multiple rings per red cell, applique forms and a parasitaemia of 6%, with no mature trophozoites or schizonts. The species, the required reporting and the treatment implication are:

1. Plasmodium vivax; chloroquine
2. Plasmodium falciparum with high parasitaemia (severe malaria by parasitaemia criteria in a non-immune patient), reported urgently by telephone with the species and percentage parasitaemia, confirmed by thin film and rapid antigen test (HRP2), with intravenous artesunate recommended and repeat films to monitor clearance; vivax and ovale additionally require primaquine for hypnozoites after G6PD testing, which matters in Gulf populations
3. Babesia; exchange transfusion
4. Plasmodium malariae; observation

Answer: B. Imported malaria is common in the Gulf's South Asian and African workforce; three negative films 12 to 24 hours apart are needed to exclude malaria.

Fungi, viruses and serology

Question 12

Blood cultures from an ICU patient on broad-spectrum antibiotics grow a yeast identified by MALDI-TOF as Candida auris. The laboratory and infection control response is:

1. Report as Candida species; no special action
2. Confirm the identification (older biochemical systems misidentify C. auris as C. haemulonii or other species), perform antifungal susceptibility testing because fluconazole resistance is usual and some isolates are multidrug-resistant, notify infection control immediately for single-room contact precautions, screening of contacts (axilla and groin swabs), enhanced environmental cleaning with sporicidal or chlorine-based agents, and reporting to public health; an echinocandin is the empirical treatment
3. Treat with fluconazole
4. Discharge the patient

Answer: B. Candida auris has caused persistent outbreaks in Gulf hospitals; it survives on surfaces for weeks and colonises patients for months.

Question 13

A neutropenic patient with leukaemia has fever unresponsive to antibiotics, nodular lung lesions with a halo sign on CT, and a serum galactomannan index of 1.2. The interpretation is:

1. Bacterial pneumonia; change antibiotics
2. Probable invasive aspergillosis by EORTC/MSG criteria (host factor, clinical and radiological features, and mycological evidence from galactomannan), supporting voriconazole or isavuconazole treatment, with bronchoalveolar lavage for galactomannan, culture and PCR where feasible; false-positive galactomannan can occur with some beta-lactam antibiotics and in neonates
3. Pneumocystis pneumonia; co-trimoxazole
4. Tuberculosis; four-drug therapy

Answer: B. Mucormycosis, which rose sharply with COVID-19 and uncontrolled diabetes, presents with a reverse halo sign and needs urgent debridement and amphotericin B.

Question 14

Which HIV testing algorithm is recommended for a diagnostic laboratory?

1. A single rapid test is sufficient for diagnosis
2. A fourth-generation antigen/antibody immunoassay as the screening test, with reactive results confirmed by an HIV-1/HIV-2 antibody differentiation assay and, where that is negative or indeterminate, HIV-1 RNA testing to detect acute infection; a second sample confirms identity before the result is issued, pre- and post-test counselling and confidentiality rules apply, and Gulf states require HIV testing for residency with defined legal consequences, which makes accuracy and confidentiality essential
3. Western blot alone
4. CD4 count as the diagnostic test

Answer: B. The window period for fourth-generation assays is about two to four weeks; hepatitis B surface antigen and hepatitis C antibody with reflex RNA testing complete the residency screen.

Question 15

A healthcare worker's pre-employment serology shows HBsAg negative, anti-HBc positive and anti-HBs positive. The interpretation is:

1. Acute hepatitis B infection
2. Resolved past hepatitis B infection with natural immunity; no vaccination needed, but if immunosuppression or chemotherapy is planned, HBV DNA monitoring or prophylaxis is considered because of reactivation risk; isolated anti-HBs with negative anti-HBc indicates vaccine immunity, and isolated anti-HBc needs HBV DNA testing to exclude occult infection
3. Vaccine-induced immunity
4. Chronic hepatitis B

Answer: B. Healthcare workers performing exposure-prone procedures are tested for HBV DNA levels under occupational health rules in the Gulf.

Infection control, biosafety and stewardship

Question 16

Three patients in one surgical ward develop Pseudomonas aeruginosa wound infections within a week. The microbiologist's outbreak investigation should include:

1. Treating each patient and waiting for more cases
2. Confirming the outbreak against baseline rates with a case definition, line listing, reviewing antibiograms for similarity, typing isolates (pulsed-field gel electrophoresis or whole genome sequencing) to confirm clonality, environmental and water sampling (sink traps, tap outlets and reusable equipment are classic Pseudomonas reservoirs), reviewing hand hygiene and instrument reprocessing, implementing control measures and communicating findings to the infection control committee and, where required, public health
3. Closing the hospital
4. Changing the empirical antibiotic only

Answer: B. Whole genome sequencing is increasingly the standard for outbreak confirmation; waterborne Pseudomonas outbreaks have been linked to hospital plumbing in several Gulf facilities.

Question 17

Which practice is required for safe handling of specimens that may contain Brucella, Mycobacterium tuberculosis, MERS-CoV or Neisseria meningitidis cultures?

1. Open-bench work with gloves only
2. Work in a class II biological safety cabinet for all open manipulations of respiratory specimens and cultures, with containment level 3 facilities for culture of Brucella, M. tuberculosis and similar hazard group 3 agents, no sniffing of plates, sealed centrifuge rotors, risk assessment before MALDI-TOF or automated identification of suspected hazard group 3 organisms, immunisation and health surveillance of staff, spill and exposure procedures, and reporting of laboratory-acquired infections
3. Autoclaving all specimens before culture
4. Ultraviolet light alone

Answer: B. Brucella is the most common laboratory-acquired bacterial infection worldwide; inadvertent open-bench handling of unexpected isolates triggers exposure management for all staff present.

Question 18

Which measure has the strongest evidence for reducing ventilator-associated pneumonia from a microbiology and infection control perspective?

1. Routine surveillance cultures of endotracheal aspirates with pre-emptive antibiotics
2. A care bundle: head of bed elevation, daily sedation interruption and readiness-to-wean assessment, oral care, subglottic secretion drainage, cuff pressure control and avoiding unnecessary circuit changes, supported by surveillance of VAP rates using standard definitions and feedback to units; routine surveillance cultures are not recommended because colonisation does not equal infection
3. Prophylactic systemic antibiotics for all ventilated patients
4. Changing ventilator circuits daily

Answer: B. Quantitative or semi-quantitative culture of lower respiratory samples (BAL threshold 10⁴ CFU/mL, aspirate 10⁵ CFU/mL) distinguishes infection from colonisation when pneumonia is suspected.

Question 19

Which element is central to an effective antimicrobial stewardship programme that the microbiologist leads or supports?

1. Restricting all antibiotics without clinical review
2. A multidisciplinary team (infectious diseases physician, clinical microbiologist, pharmacist, infection control), local empirical guidelines based on the hospital antibiogram, prospective audit with feedback and pre-authorisation of restricted agents (carbapenems, colistin, linezolid), de-escalation and intravenous-to-oral switch prompts, dose optimisation using therapeutic drug monitoring, measurement of consumption (defined daily doses) and resistance trends, and education; cumulative antibiograms are published annually following CLSI M39 principles
3. Reporting every antibiotic tested on every isolate
4. Allowing unrestricted carbapenem use

Answer: B. Gulf national action plans on antimicrobial resistance require stewardship programmes in hospitals, and accreditation surveys audit them.

Question 20

Which statement about quality control in the microbiology laboratory is correct?

1. Media and discs do not require quality control if purchased commercially
2. Reference strains (for example Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213, Pseudomonas aeruginosa ATCC 27853) are tested with each new lot of media, discs and gradient strips and at defined intervals, with results within published ranges before patient results are released; incubators, biosafety cabinets and autoclaves are monitored and documented; external quality assessment schemes are joined for identification and susceptibility testing; and sample rejection criteria, turnaround times and critical result communication are monitored under ISO 15189 or CAP accreditation
3. Reference strains are tested annually
4. External quality assessment is optional

Answer: B. A failed QC result invalidates the batch until the cause is corrected; Gulf authorities require accreditation for hospital laboratories.

How to practise

• Learn the resistance mechanisms and their detection: ESBL, AmpC, carbapenemases by type, MRSA, VRE, and the treatment each implies.
• Know the regional pathogens: Brucella, tuberculosis and MDR-TB, MERS-CoV, imported malaria, Candida auris, meningococcal disease at mass gatherings.
• Know the algorithms: blood culture interpretation, C. difficile testing, HIV and hepatitis B serology, fungal biomarkers.
• Know biosafety, outbreak investigation and stewardship as the microbiologist's management responsibilities.
• Practise under time in the Medical Microbiology bank, or the Microbiology Technologist bank and Microbiology Clinical Scientist bank for those titles, using the error-log method.

Related sets: haematopathology questions, anatomic pathology questions, infection control questions and lab technologist questions.

Frequently asked questions

How many questions are in the Prometric medical microbiology exam?

Typically 100 to 150 single-best-answer MCQs in up to three hours, with a pass mark of about 60%, varying by authority.

Which microbiology topics come up most?

Antimicrobial resistance detection and reporting, blood culture interpretation, tuberculosis and brucellosis, MERS-CoV and respiratory viruses, Candida auris, serology algorithms, outbreak investigation, biosafety and stewardship.

Does the exam include virology and parasitology?

Yes. Clinical virology (HIV, hepatitis, respiratory viruses, MERS-CoV) and parasitology (malaria, intestinal parasites) are part of the general microbiology paper.

Is the microbiology technologist exam different?

It shares the bench content (culture, identification, susceptibility, quality control, biosafety) but places less weight on clinical interpretation, stewardship and outbreak management.

Are these real exam questions?

No. They are original practice questions written to the published blueprint. Real exam content is confidential.